We are live on
!
Find out more
CCM
Catapult Capital Management Portfolio holdings
AUM
$265M
1-Year Est. Return
21.83%
This Fund
S&P 500
This Quarter
Est. Return
+8.73%
1 Year Est. Return
+21.83%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$500M
AUM Growth
+$80.3M
(+19%)
Cap. Flow
+$50.8M
Cap. Flow
% of AUM
10.17%
Top 10 Holdings %
Top 10 Hldgs %
33.29%
Holding
297
New
113
Increased
37
Reduced
42
Closed
105
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FWLT
FOSTER WHEELER AG (SWITZERLAND)
FWLT
|
+$31.5M |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$25.9M |
| 3 |
FRX
FOREST LABORATORIES INC
FRX
|
+$21.1M |
| 4 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$20.3M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$13.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LIFE
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
|
+$22.7M |
| 2 |
AGN
Allergan plc
AGN
|
+$19M |
| 3 |
SHPG
Shire pic
SHPG
|
+$12.5M |
| 4 |
Zimmer Biomet
ZBH
|
+$8.97M |
| 5 |
Perrigo
PRGO
|
+$8.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.41% |
| 2 | Consumer Discretionary | 12.28% |
| 3 | Materials | 11.51% |
| 4 | Communication Services | 11.07% |
| 5 | Industrials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Bristol-Myers Squibb
BMY
$133B
| – | – |
-85,000
| Closed | -$4.52M |
|
|
202
PUT
Bristol-Myers Squibb
BMY
$133B
| – | – |
-100,000
| Closed | -$5.32M |
|
203
Burlington
BURL
$23.2B
| – | – |
-8,476
| Closed | -$271K |
|
204
Conagra Brands
CAG
$6.95B
| – | – |
-33,918
| Closed | -$890K |
|
205
Caleres
CAL
$432M
| – | – |
-63,002
| Closed | -$1.77M |
|
206
Charter Communications
CHTR
$17.3B
| – | – |
-6,619
| Closed | -$905K |
|
207
Comcast
CMCSA
$85B
| – | – |
-29,030
| Closed | -$754K |
|
208
CME Group
CME
$96.3B
| – | – |
-2,589
| Closed | -$203K |
|
209
Coty
COTY
$2.42B
| – | – |
-83,285
| Closed | -$1.27M |
|
210
Crocs
CROX
$6.36B
| – | – |
-101,431
| Closed | -$1.61M |
|
211
CVS Health
CVS
$133B
| – | – |
-35,301
| Closed | -$2.53M |
|
212
Dollar General
DG
$28B
| – | – |
-7,205
| Closed | -$435K |
|
213
DexCom
DXCM
$32.2B
| – | – |
-29,508
| Closed | -$261K |
|
214
EOG Resources
EOG
$79.2B
| – | – |
-8,888
| Closed | -$746K |
|
215
Equinix
EQIX
$101B
| – | – |
-4,345
| Closed | -$771K |
|
216
Fortune Brands Innovations
FBIN
$5.88B
| – | – |
-25,371
| Closed | -$991K |
|
217
Freeport-McMoran
FCX
$90B
| – | – |
-7,792
| Closed | -$294K |
|
218
iShares China Large-Cap ETF
FXI
$4.37B
| – | – |
-21,490
| Closed | -$825K |
|
219
The Greenbrier Companies
GBX
$1.52B
| – | – |
-8,735
| Closed | -$287K |
|
220
General Dynamics
GD
$104B
| – | – |
-3,019
| Closed | -$288K |
|
221
Gilead Sciences
GILD
$162B
| – | – |
-45,000
| Closed | -$3.38M |
|
222
Gaming and Leisure Properties
GLPI
$12.7B
| – | – |
-8,115
| Closed | -$412K |
|
223
General Motors
GM
$80.4B
| – | – |
-4,547
| Closed | -$186K |
|
|
HBI
224
DELISTED
Hanesbrands
HBI
| – | – |
-194,276
| Closed | -$3.41M |
|
225
Humana
HUM
$43.7B
| – | – |
-13,378
| Closed | -$1.38M |
|
Similar funds
LOCB
AF
TCOTO
DCM
SCA
LPVHS
ATC
TFF
Catapult Capital Management's Q1 2014 Portfolio in Review
As of Q1 2014, Catapult Capital Management held 297 positions worth $500M, up 19% from $420M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Catapult Capital Management deployed $50.8M of net new capital in Q1 2014, opening 113 new positions and adding to 37 existing holdings. Its largest new stake was BEAM INC COM STK (DE): 249,647 shares worth $20.8M.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 40% a quarter earlier, followed by Consumer Discretionary and Materials.
On the sell side, the largest reduction was Allergan plc, an estimated $19M trimmed.
- Catapult Capital Management's largest Q1 2014 buy was BEAM INC COM STK (DE): 249,647 shares worth $20.8M.
- Catapult Capital Management added most to FOSTER WHEELER AG (SWITZERLAND) in Q1 2014, an estimated $31.5M increase.
- Catapult Capital Management's biggest Q1 2014 reduction was Allergan plc, cutting an estimated $19M.
- Catapult Capital Management fully exited LIFE TECHNOLOGIES CORP COM STK (DE) in Q1 2014, selling an estimated $22.7M.
- Catapult Capital Management's ten largest holdings make up 33% of its $500M portfolio in Q1 2014.
- Catapult Capital Management opened 113 new positions and closed 105 in Q1 2014.
- Catapult Capital Management's portfolio value rose 19% quarter-over-quarter to $500M.
Based on Catapult Capital Management's 13F filing for Q1 2014, filed 15 May 2014.